AIFC
AI Financial CorpCompany with tickers: ALTS
CIK
862861
CUSIP
47089W104
Shares Outstanding
139,836,511
Website
https://www.alt5sigma.com
Investor Relations
https://www.alt5sigma.com/investors
13F Activity (30d)
5 filings
4 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $4,712,000 | USD | 2026-03-28 | 10-Q | 2026-05-18 |
| Cost of Revenue | $1,138,000 | USD | 2026-03-28 | 10-Q | 2026-05-18 |
| Gross Profit | $3,574,000 | USD | 2026-03-28 | 10-Q | 2026-05-18 |
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-2,743,000 | USD | 2026-03-28 | 10-Q | 2026-05-18 |
| Net Income | $-271,493,000 | USD | 2026-03-28 | 10-Q | 2026-05-18 |
| EPS (Basic) | $-2.14 | USD/shares | 2026-03-28 | 10-Q | 2026-05-18 |
| EPS (Diluted) | $-2.14 | USD/shares | 2026-03-28 | 10-Q | 2026-05-18 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (USD)
| Component | 2022-01-01 | 2022-12-31 | 2023-12-30 | 2024-12-28 | 2025-12-27 |
|---|---|---|---|---|---|
| Segments Total | — | — | — | $11,887,000 | $24,840,000 |
| Total Reportable Segments | — | — | — | $11,887,000 | $24,840,000 |
| Biotechnology | — | — | $0 | $0 | — |
| Fintech | — | — | $0 | $12,532,000 | — |
| Biotechnology | — | $0 | $0 | — | — |
| Recycling | $40,022,000 | $39,611,000 | — | — | — |
| Corporate And Other | — | — | $0 | $0 | — |